Li, Jianping

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., Budaj, A. J., Diaz, R., Goodman, S. G., Hanotin, C., et al. (2019) · The Lancet Diabetes & Endocrinology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 315

Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis

Li, M., Ma, W., Fan, F., Yi, T., Qiu, L., Wang, Z., Weng, H., Zhang, Y., Li, J., & Huo, Y. (2023) · Journal of Cardiology

Heart Failure Treatment and ManagementBlood Pressure and Hypertension Studies

Cited by 22